Literature DB >> 32590920

Application of intra-operative magnetic resonance imaging for intracranial epidermoid cysts.

Akihide Kondo1, Osamu Akiyama1, Shigeki Aoki2, Hajime Arai1.   

Abstract

The effectiveness and safety of intraoperative magnetic resonance imaging (iMRI) are evident from many reports over the past decade. However, these reports have mainly concerned surgeries for glioma and other intra-axial tumours, and applications of this approach for extra-axial tumours are poorly documented. We retrospectively examined three cases in which iMRI was used to assist in the removal of epidermoid cysts. T2-weighted images and diffusion-weighted images were acquired during the surgeries. The value to surgeons of images generated by iMRI, the length of interruption of surgery, and the safety of the patients were assessed. In this study, the images obtained through iMRI provided were clear representations of remnant tumours, even with a low-field system (0.4 Tesla). These images generated enough information to help surgeons decide whether to use an assistance device, such as an endoscope, to remove remnant tumours and whether further retraction of the brain was safe for patients and useful in tumour removal. Intraoperative MRI has long been thought unnecessary for surgery for tumours that are well demarcated and clearly visible under a surgical microscope; in this study, however, intraoperative MRI proved to be useful and safe for patients undergoing epidermoid cyst resection.

Entities:  

Keywords:  Intraoperative imaging; MRI; endoscopic tumour removal; epidermoid cyst

Year:  2020        PMID: 32590920     DOI: 10.1080/02688697.2020.1784844

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  1 in total

1.  Artificial Intelligence Algorithm-Based Intraoperative Magnetic Resonance Navigation for Glioma Resection.

Authors:  Jianqiang Wei; Chunman Zhang; Liujia Ma; Chunrui Zhang
Journal:  Contrast Media Mol Imaging       Date:  2022-03-04       Impact factor: 3.161

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.